Reviva Pharmaceuticals Holdings ( (RVPH) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Reviva Pharmaceuticals Holdings, Inc. has announced a delay in filing its Annual Report on Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the need for additional time to complete and finalize the financial statements and related audit procedures. The company has cited expected material weaknesses in its internal control over financial reporting and disclosure controls as contributing factors. Reviva Pharmaceuticals anticipates filing the delayed report within fifteen calendar days following the prescribed due date. The company does not expect any significant changes in its financial results from the previous fiscal year. The notification of late filing was signed by Narayan Prabhu, the Chief Financial Officer, as part of the company’s ongoing compliance efforts.
More about Reviva Pharmaceuticals Holdings
YTD Price Performance: -49.75%
Average Trading Volume: 1,478,668
Technical Sentiment Signal: Buy
Current Market Cap: $47.04M
Find detailed analytics on RVPH stock on TipRanks’ Stock Analysis page.